Skip to content
lifestyle.dietfitnessforall.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ADARx Pharmaceuticals Inc.
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering
October 1, 2026
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
September 24, 2026